These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Successful treatment of nodular actinic reticuloid with tacrolimus ointment. Gröne D; Kunz M; Zimmermann R; Gross G Dermatology; 2006; 212(4):377-80. PubMed ID: 16707890 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of chronic actinic dermatitis with topical pimecrolimus. Larangeira de Almeida H Int J Dermatol; 2005 Apr; 44(4):343-4. PubMed ID: 15811093 [No Abstract] [Full Text] [Related]
10. The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia. Ogawa Y; Adachi A; Tomita Y J Dermatol; 2003 Nov; 30(11):805-9. PubMed ID: 14684938 [TBL] [Abstract][Full Text] [Related]
11. Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis. Beyerler M; Schmid-Grendelmeier P; Hafner J Dermatology; 2006; 212(3):260-1. PubMed ID: 16549924 [No Abstract] [Full Text] [Related]
12. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. Papp KA; Papp A; Dahmer B; Clark CS J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215 [TBL] [Abstract][Full Text] [Related]
13. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739 [No Abstract] [Full Text] [Related]
14. Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study. Ma Y; Lu Z J Dermatolog Treat; 2010 May; 21(3):171-7. PubMed ID: 20394493 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019 [TBL] [Abstract][Full Text] [Related]
16. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R; Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341 [TBL] [Abstract][Full Text] [Related]
17. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis. Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796 [TBL] [Abstract][Full Text] [Related]
18. An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion. Mrowietz U; Wustlich S; Hoexter G; Graeber M; Bräutigam M; Luger T Acta Derm Venereol; 2003; 83(5):351-3. PubMed ID: 14609102 [TBL] [Abstract][Full Text] [Related]
19. [Topical tacrolimus in chronic actinic dermatitis]. Girault PY; Boye T; Veran Y Ann Dermatol Venereol; 2008 Oct; 135(10):688-90. PubMed ID: 18929923 [No Abstract] [Full Text] [Related]
20. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Olson KA; West K; McCarthy PL Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]